Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Joshua Thurman and Felix Poppelaars.

 
Connection Strength
 
 
 
5.737
 
  1. Poppelaars F, Holers VM, Thurman JM. Complement biomarkers during iptacopan treatment. Lancet. 2026 Mar 28; 407(10535):1234a-1235.
    View in: PubMed
    Score: 0.973
  2. Poppelaars F, Eskandari SK, Damman J, Frazer-Abel A, Holers VM, Dixon BP, Daha MR, Sanders JF, Seelen MA, Faria B, Gaya da Costa M, Thurman JM. Association of Carboxypeptidase B2 Gene Polymorphisms With Graft Loss in Kidney Transplantation. Transplant Direct. 2026 Feb; 12(2):e1675.
    View in: PubMed
    Score: 0.960
  3. Poppelaars F, Holers VM, Thurman JM. Friend or foe: assessing the value of animal models for facilitating clinical breakthroughs in complement research. J Clin Invest. 2025 Jun 16; 135(12).
    View in: PubMed
    Score: 0.922
  4. Poppelaars F, Faria B, Thurman JM. Alternative Complement Pathway, Iptacopan, and IgA Nephropathy. N Engl J Med. 2025 May 15; 392(19):1975.
    View in: PubMed
    Score: 0.917
  5. Poppelaars F, Thurman JM. Complement-mediated kidney diseases. Mol Immunol. 2020 12; 128:175-187.
    View in: PubMed
    Score: 0.669
  6. Petr V, Purohit S, Poppelaars F, Renner B, Laskowski J, Whelan R, Kulik L, Kendrick J, Frazer-Abel A, Jalal D, Marcolin B, Schmelzer I, Debiec H, Ronco P, Saleem MA, Satchell SC, Thurman JM. Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy. J Transl Autoimmun. 2026 Jun; 12:100342.
    View in: PubMed
    Score: 0.238
  7. Renner B, Laskowski J, Poppelaars F, Whelan R, Milliron K, Petr V, Blaine J, Ozekin Y, Ferreira VP, Pickering MC, Schmidt CQ, Hajjar K, Davidson A, Thurman JM. Annexin A2 interferes with complement regulation within the glomerulus. J Biol Chem. 2025 10; 301(10):110657.
    View in: PubMed
    Score: 0.234
  8. Petr V, Tichanek F, Liu SL, Poppelaars F, Renner B, Laskowski J, Purohit S, Zhao M, Jalal D, Heeger PS, Thurman JM. Pretransplant natural antibody levels identify a subset of deceased donor kidney transplant recipients that benefit from infliximab induction. Am J Transplant. 2025 Oct; 25(10):2173-2181.
    View in: PubMed
    Score: 0.230
  9. Whelan R, Feemster A, Laskowski J, Renner B, Kulik L, Poppelaars F, Lee C, Holers VM, Thurman JM. Female but Not Male Mice Deficient in Soluble IgM Are Susceptible to Chemically Induced Glomerular Injury. J Immunol. 2023 10 15; 211(8):1240-1248.
    View in: PubMed
    Score: 0.205
  10. Renner B, Poppelaars F, Laskowski J, Serkova NJ, Kulik L, Holers VM, Thurman JM. Noninvasive Detection of iC3b/C3d Deposits in the Kidney Using a Novel Bioluminescent Imaging Probe. J Am Soc Nephrol. 2023 07 01; 34(7):1151-1154.
    View in: PubMed
    Score: 0.198
  11. Renner B, Laskowski J, Poppelaars F, Ferreira VP, Blaine J, Antonioli AH, Hannan JP, Kovacs JM, van Kooten C, You Z, Pickering MC, Holers VM, Thurman JM. Factor H related proteins modulate complement activation on kidney cells. Kidney Int. 2022 12; 102(6):1331-1344.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)